help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-1895
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/5/2964    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mosheimer, B. A.
Right arrow Articles by Wiedermann, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mosheimer, B. A.
Right arrow Articles by Wiedermann, C. J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Calcium and Bone Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 5 2964-2971
Copyright © 2005 by The Endocrine Society

Syndecan-1 Is Involved in Osteoprotegerin-Induced Chemotaxis in Human Peripheral Blood Monocytes

Birgit A. Mosheimer, Nicole C. Kaneider, Clemens Feistritzer, Angela M. Djanani, Daniel H. Sturn, Josef R. Patsch and Christian J. Wiedermann

Division of General Internal Medicine, Department of Internal Medicine, Medical University of Innsbruck, A-6020 Innsbruck, Austria

Address all correspondence and requests for reprints to: Professor Dr. Christian J. Wiedermann, Department of Internal Medicine, Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria. E-mail: christian.wiedermann{at}uibk.ac.at.

Chronic inflammation is characterized by tissue infiltration with monocytes/macrophages, which possess broad proinflammatory, destructive, and remodeling capacities. Elevated levels of osteoprotegerin, an important regulator of differentiation and activation of osteoclasts that also affects different cells of the immune system, were found in the serum of patients with chronic inflammatory diseases. The study of whether osteoprotegerin affects monocyte locomotion in vitro and the possible mechanisms and pathways involved was investigated using Boyden microchemotaxis chambers and Western blot analyses. Osteoprotegerin significantly stimulated monocyte chemotaxis, whereas preincubation of monocytes with osteoprotegerin inhibited monocyte migration toward optimal concentrations of regulated upon activation normal T cell expressed and secreted, monocyte chemotactic protein –1, and procalcitonin. The effects of osteoprotegerin were abolished by pretreating cells with heparinase I and chondroitinase or antibodies against the ectodomain of syndecan-1. Osteoprotegerin signaling was shown to involve protein kinase C, phosphatidylinositol 3-kinase/Akt, and tyrosine kinase.

Data suggest that osteoprotegerin affects monocyte mi-gration and protein kinase C and phosphatidylinositol 3-kinase/Akt activation via syndecan-1. Osteoprotegerin-induced deactivation of monocyte chemotaxis toward different chemokines is due to interaction of osteoprotegerin with heparan sulfate and chondroitin sulfate.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Kim, S. Wilcox-Adelman, Y. Sano, W.-J. Tang, R. J. Collier, and J. M. Park
From the Cover: Antiinflammatory cAMP signaling and cell migration genes co-opted by the anthrax bacillus
PNAS, April 22, 2008; 105(16): 6150 - 6155.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Lawrie, E. Waterman, M. Southwood, D. Evans, J. Suntharalingam, S. Francis, D. Crossman, P. Croucher, N. Morrell, and C. Newman
Evidence of a Role for Osteoprotegerin in the Pathogenesis of Pulmonary Arterial Hypertension
Am. J. Pathol., January 1, 2008; 172(1): 256 - 264.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Zauli, F. Corallini, F. Bossi, F. Fischetti, P. Durigutto, C. Celeghini, F. Tedesco, and P. Secchiero
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo
Blood, July 15, 2007; 110(2): 536 - 543.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
R. Pakula, A. Melchior, A. Denys, C. Vanpouille, J. Mazurier, and F. Allain
Syndecan-1/CD147 association is essential for cyclophilin B-induced activation of p44/42 mitogen-activated protein kinases and promotion of cell adhesion and chemotaxis
Glycobiology, May 1, 2007; 17(5): 492 - 503.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society